# US 2021/0174927 A1 · Method and Apparatus for Delivering a Substance to an Individual

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0174927 A1
- Document ID: US20210174927A1
- Status: Published application
- Kind: A1
- Application number: 17/179,187
- Filed: 2021-02-18
- Published: 2021-06-10
- Earliest claimed: 2015-10-22
- Assignees: Welch Allyn, Inc.
- Applicants: Welch Allyn, Inc.
- Inventors: John A. Lane
- Web page: https://patentgrep.com/patent/US20210174927A1

## CPC

- G16H 20/17: delivered via infusion or injection
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 5/024: Measuring pulse rate or heart rate
- A61B 5/4839: {combined with drug delivery}
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- A61B 5/6814: {Head}
- A61B 5/68335: {including release sheets or liners}
- A61B 5/6846: {specially adapted to be brought in contact with an internal body part, i.e. invasive}
- G16C 20/30: Prediction of properties of chemical compounds, compositions or mixtures
- A61M 2037/0023: {Drug applicators using microneedles}
- A61M 2205/33: Controlling, regulating or measuring
- A61M 2230/005: Parameter used as control input for the apparatus
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Aspects of the subject disclosure may include, for example, detecting, by a substance delivery system coupled to a body part of an individual, an input signal not associated with a biological measurement of the individual, determining from the input signal, by the substance delivery system, whether delivering a dosage of a substance stored in the substance delivery system is needed and conforms to a dosage policy, and responsive to determining from the input signal that delivery of the dosage of the substance is needed and conforms to the dosage policy, initiating, by the substance delivery system, delivery of the dosage of the substance to the body part of the individual. Other embodiments are disclosed.

## Claims

### Claim 1

A method comprising:
delivering, by a microfluidic system of a sensing device coupled to a body part of an individual at a first time, a first dosage of a substance;
receiving, by the sensing device at a second time, a first request by the individual to administer a second dosage of the substance;
determining, by the sensing device, that a first time period between the first time and the second time is less than a minimum amount of time required between consecutive dosage deliveries of the substance;
receiving, by the sensing device at a third time, a second request by the individual to administer the second dosage of the substance;
determining, by the sensing device, that a second time period between the first time and the third time is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance; and
responsive to determining that the second time period is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance, initiating, by the microfluidic system, delivery of the second dosage of the substance to the body part of the individual.

### Claim 2 (depends on 1)

The method of claim 1, wherein the minimum amount of time is based at least in part on an amount of the substance that will lessen an effectiveness of the substance when delivered to the individual.

### Claim 3 (depends on 1)

The method of claim 1, further comprising:
obtaining, by the sensing device, sensing data associated with a biological measurement of the individual; and
determining from the biological measurement that the second dosage has improved a biological condition of the individual adjustable by the second dosage.

### Claim 4 (depends on 3)

The method of claim 3, further comprising adapting one or more of a procedure, a treatment, or a timer associated with the biological condition based at least in part on determining that the second dosage has improved the biological condition.

### Claim 5 (depends on 1)

The method of claim 1, further comprising:
obtaining, by the sensing device, sensing data associated with a biological measurement of the individual; and
determining from the biological measurement that the second dosage has failed to improve a biological condition of the individual adjustable by the second dosage.

### Claim 6 (depends on 5)

The method of claim 5, further comprising adapting one or more of a procedure, a treatment, or a timer associated with the biological condition based at least in part on determining that the second dosage has failed to improve the biological condition.

### Claim 7 (depends on 1)

The method of claim 1, further comprising preventing the second dosage from being delivered by the microfluidic system prior to receiving the second request and based at least in part on determining that the first time period is less than the minimum amount of time required between consecutive deliveries of the substance.

### Claim 8

A system comprising:
a microfluidic delivery device coupled to a body part of an individual;
a sensing device;
one or more processors; and
one or more non-transitory computer-readable media storing instructions that, when executed by the one or more processors, cause the one or more processors to perform operations comprising:
causing the microfluidic delivery device to deliver a first dosage of a substance at a first time;
receiving, from the sensing device at a second time, a first request by the individual to administer a second dosage of the substance;
determining that a first time period between the first time and the second time is less than a minimum amount of time required between consecutive dosage deliveries of the substance;
receiving, from the sensing device at a third time, a second request by the individual to administer the second dosage of the substance;
determining that a second time period between the first time and the third time is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance; and
responsive to determining that the second time period is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance, causing the microfluidic delivery device to deliver the second dosage of the substance to the body part of the individual.

### Claim 9 (depends on 8)

The system of claim 8, wherein the microfluidic delivery device comprises one or more micro-needles, one or more reservoirs configured to store the substance, and a piezo inkjet coupled to the one or more reservoirs and configured to deliver, in response to an instruction received from the one or more processors, the substance via the one or more micro-needles from the one or more reservoirs.

### Claim 10 (depends on 8)

The system of claim 8, wherein the sensing device comprises a button, and wherein the first request and the second request are associated with the individual pressing the button.

### Claim 11 (depends on 8)

The system of claim 8, wherein the sensing device comprises a touch sensitive interface, and wherein the first request and the second request are associated with the individual providing a touch input at the touch sensitive interface.

### Claim 12 (depends on 8)

The system of claim 8, the operations further comprising:
determining an environmental condition of an environment surrounding the individual; and
determining a dosage policy associated with the environmental condition,
wherein the minimum amount of time, a first amount associated with the first dosage, or a second amount associated with the second dosage are based at least in part on the dosage policy.

### Claim 13 (depends on 12)

The system of claim 12, wherein the environmental condition is associated with:
motion being experienced by the individual and determined based at least in part on motion data received from a motion sensor, or
air particulates in air surrounding the individual in the environment and determined based at least in part on particulate data received from a particulate sensor.

### Claim 14 (depends on 8)

The system of claim 8, wherein the minimum amount of time is based at least in part on an amount of the substance that will cause an overdose of the substance when delivered to the individual.

### Claim 15

One or more non-transitory computer-readable media storing instructions that, when executed by one or more processors, cause the one or more processors to perform operations comprising:
delivering, by a microfluidic system of a sensing device coupled to a body part of an individual at a first time, a first dosage of a substance;
receiving, by the sensing device at a second time, a first request by the individual to administer a second dosage of the substance;
determining, by the sensing device, that a first time period between the first time and the second time is less than a minimum amount of time required between consecutive dosage deliveries of the substance;
receiving, by the sensing device at a third time, a second request by the individual to administer the second dosage of the substance;
determining, by the sensing device, that a second time period between the first time and the third time is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance; and
responsive to determining that the second time period is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance, initiating, by the microfluidic system, delivery of the second dosage of the substance to the body part of the individual.

### Claim 16 (depends on 15)

The one or more non-transitory computer-readable media of claim 15, wherein the minimum amount of time is based at least in part on an amount of the substance that will lessen an effectiveness of the substance when delivered to the individual.

### Claim 17 (depends on 15)

The one or more non-transitory computer-readable media of claim 15, wherein the microfluidic system comprises one or more micro-needles, one or more reservoirs configured to store the substance, and a piezo inkjet coupled to the one or more reservoirs and configured to deliver, in response to an instruction received from the one or more processors, the substance via the one or more micro-needles from the one or more reservoirs.

### Claim 18 (depends on 15)

The one or more non-transitory computer-readable media of claim 15, the operations further comprising:
determining an environmental condition of an environment surrounding the individual; and
determining a dosage policy associated with the environmental condition,
wherein the minimum amount of time, a first amount associated with the first dosage, or a second amount associated with the second dosage are based at least in part on the dosage policy.

### Claim 19 (depends on 18)

The one or more non-transitory computer-readable media of claim 18, wherein the environmental condition is associated with:
motion being experienced by the individual and determined based at least in part on motion data received from a motion sensor, or
air particulates in air surrounding the individual in the environment and determined based at least in part on particulate data received from a particulate sensor.

### Claim 20 (depends on 15)

The one or more non-transitory computer-readable media of claim 15, further comprising preventing the second dosage from being delivered by the microfluidic system prior to receiving the second request and based at least in part on determining that the first time period is less than the minimum amount of time required between consecutive deliveries of the substance.
